Get started
Author

Hannes Fohler

Palbociclib with adjuvant endocrine therapy in early breast cancer (PALLAS): interim analysis of a multicentre, open-label, randomised, phase 3 study
2021 · Erica L Mayer, Amylou C Dueck, et al. · The Lancet Oncology · 261
Adjuvant Palbociclib for Early Breast Cancer: The PALLAS Trial Results (ABCSG-42/AFT-05/BIG-14-03)
2021 · Michael Gnant, Amylou C. Dueck, et al. · Journal of Clinical Oncology · 235
PDF
Long-Term Outcomes of Adjuvant Denosumab in Breast Cancer
2022 · Michael Gnant, Sophie Frantal, et al. · NEJM Evidence · 50
Extending the duration of endocrine treatment for early breast cancer: patient-level meta-analysis of 12 randomised trials of aromatase inhibitors in 22 031 postmenopausal women already treated with at least 5 years of endocrine therapy
2025 · Jeremy Braybrooke, Rosie Bradley, et al. · The Lancet · 41
Impact of BMI in Patients With Early Hormone Receptor–Positive Breast Cancer Receiving Endocrine Therapy With or Without Palbociclib in the PALLAS Trial
2023 · Georg Pfeiler, Dominik Hlauschek, et al. · Journal of Clinical Oncology · 36
LBA12 PALLAS: A randomized phase III trial of adjuvant palbociclib with endocrine therapy versus endocrine therapy alone for HR+/HER2- early breast cancer
2020 · E.L. Mayer, M.I. Gnant, et al. · Annals of Oncology · 29
PDF
Maintaining Bone Density in Patients Undergoing Treatment for Breast Cancer: Is There an Adjuvant Benefit?
2009 · Michael Gnant, Peter Dubsky, et al. · Clinical Breast Cancer · 13
Does the number of 6-monthly adjuvant zoledronate infusions received affect treatment efficacy for early breast cancer? A sub-study of ABCSG-12
2022 · Ana-Alicia Beltran-Bless, Mark J. Clemons, et al. · European Journal of Cancer · 10
The future of clinical trials—goals, ideas, and discussion
2024 · Michael Gnant, Manuela Gili, et al. · memo - Magazine of European Medical Oncology · 5
PDF
Abstract GS1-07: Adjuvant palbociclib in HR+/HER2- early breast cancer: Final results from 5,760 patients in the randomized phase III PALLAS trial
2022 · Michael Gnant, Amylou C Dueck, et al. · Cancer Research · 1
Abstract PS2-07-11: The improved long-term outcome in denosumab-treated postmenopausal women with early luminal breast cancer in Abcsg 18 is driven by progesterone receptor-positive tumors
2026 · C. Singer, D. Hlauschek, et al. · Clinical Cancer Research
Abstract P2-02-04: De-escalation of bone-targeted treatment: Does the number of 6-monthly adjuvant zoledronate infusions received affect treatment efficacy for early breast cancer? A sub-study of ABCSG-12
2023 · Ana-Alicia Beltran-Bless, Mark Clemons, et al. · Cancer Research
Abstract P6-21-02: Withdrawn
2019 · C Minichsdorfer, E Bergen, et al. · Cancer Research
Works count: 13
Citation count: 681
H-index: 8
I10-index: 8
Year
Topic
Type